|
The United States is considering policies that would import overseas pricing and reimbursement for health care – this time for medicines – from other countries. These foreign countries differ greatly from the U.S. in many ways, and perhaps most fundamentally, in the value they place on disabled lives.
PIPC and more than 100 organizations representing patients, people with disabilities, and older adults submitted a letter to the Center for Medicare and Medicaid Innovation (CMMI) regarding the use of the GLOBE and GUARD models proposed as payment models for CMMI that would import QALYs and similar measures as used in other countries.
PIPC shared the concerns of patients and people with disabilities related to efforts in Virginia to establish a Prescription Drug Affordability Board (PDAB) with the Virginia Subcommittee on Health and Human Resources in a letter to the sponsors of bills that would devalue patients, people with disabilities, and older adults.
PIPC recently submitted a letter to the sponsors of legislation (HB 483/SB 271) in Virginia that would allow the use of discriminatory "value" assessment metrics like the quality-adjusted-life-years (QALY) in health care coverage decisions.
As Florida’s legislative session gets underway, lawmakers there are considering tying prescription drug prices in the state to those in other countries that rely on quality-adjusted life years (QALYs) to value health services and treatments.
The Global Liver Institute (GLI) submitted a comment letter to the Institute for Clinical and Economic Review (ICER) related to its most recent draft evidence report on obesity.
The Partnership to Improve Patient Care (PIPC) recently submitted a letter to the Minnesota Prescription Drug Affordability Board (PDAB) to share concerns of patients and people with disabilities related to the PDAB’s potential use of cost effectiveness analyses.
Since passage of the Inflation Reduction Act, PIPC has worked collaboratively with organizations representing patients and people with disabilities to amplify the perspectives of those with lived experience in the implementation of the Medicare Drug Price Negotiation Program.
The Partnership to Improve Patient Care (PIPC) and 34 organizations representing patients, people with disabilities, and older adults submitted a comment letter to the Centers for Medicare and Medicaid Services (CMS) on the third cycle of the Medicare Drug Price Negotiation Program.
PIPC Chairman Tony Coelho recently penned a letter to Nevada Governor Joe Lombardo urging a veto of legislation (AB 259) that would discriminate against patients, people with disabilities. and older adults.
|
Topics
All
Archives
August 2026
|
